+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Facial Erythema Drug"

Facial Erythema Treatment Market 2024-2028 - Product Thumbnail Image

Facial Erythema Treatment Market 2024-2028

  • Report
  • November 2024
  • 156 Pages
  • Global
From
  • 2 Results (Page 1 of 1)
Loading Indicator

Facial Erythema is a condition characterized by redness and inflammation of the skin on the face. It is often caused by sun exposure, allergies, or other skin conditions. Dermatological Drugs are medications used to treat skin conditions, including facial erythema. These drugs can be topical, oral, or injectable, and are used to reduce inflammation, reduce redness, and improve skin health. Common treatments for facial erythema include topical corticosteroids, oral antibiotics, and topical retinoids. The Facial Erythema Drug market is a subset of the larger Dermatological Drugs market. It is composed of companies that specialize in the development and manufacture of drugs used to treat facial erythema. These companies include Allergan, Galderma, and Sun Pharmaceuticals. Show Less Read more